INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL

被引：0
|
作者：
Kebir, Sied [1 ,2 ]
Lazaridis, Lazaros [1 ,2 ]
Schmidt, Teresa [1 ,2 ]
Oster, Christoph [1 ,2 ]
Feldheim, Jonas [3 ,4 ]
Pierscianek, Daniela [5 ]
Proescholdt, Martin [6 ]
Hau, Peter [7 ,8 ]
Grosu, Anca-Ligia [9 ]
Krex, Dietmar [10 ]
Sure, Ulrich [11 ]
Scheffler, Bjoern [12 ]
Kleinschnitz, Christoph [1 ,2 ]
Poettgen, Christoph [13 ]
Stuschke, Martin [14 ]
Glas, Martin [1 ,2 ]
机构：
[1] Univ Duisburg Essen, Univ Med Essen, Dept Neurol, Essen, Germany
[2] Univ Duisburg Essen, Univ Med Essen, Div Clin Neurooncol, Ctr Translat Neuro & Behav Sci C TNBS, Essen, Germany
[3] Univ Med Essen, Dept Neurol, Essen, Germany
[4] Univ Med Essen, Div Clin Neurooncol, Ctr Translat Neuro & Behav Sci C TNBS, Essen, Germany
[5] Univ Med Essen, Dept Neurosurg & Spine Surg, Essen, Germany
[6] Univ Regensburg, Dept Neurosurg, Med Ctr, Regensburg, Germany
[7] Univ Hosp Regensburg, Dept Neurol, Regensburg, CA USA
[8] Univ Hosp Regensburg, Wilhelm Sander Neurooncol Unit, Regensburg, CA USA
[9] Med Ctr Univ Freiburg, Dept Radiat Oncol, Freiburg, Germany
[10] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Neurosurg, Dresden, Germany
[11] Univ Duisburg Essen, Univ Med Essen, Dept Neurosurg & Spine Surg, Essen, Germany
[12] German Canc Res Ctr, Heidelberg, Germany
[13] Univ Med Essen, Dept Radiotherapy, Essen, Germany
[14] Univ Duisburg Essen, Univ Med Essen, Dept Radiotherapy, Essen, Germany
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CTNI-65
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma
    Brown, Paul D.
    Chung, Caroline
    Liu, Diane D.
    McAvoy, Sarah
    Grosshans, David
    Al Feghali, Karine
    Mahajan, Anita
    Li, Jing
    McGovern, Susan L.
    Mcaleer, Mary-Fran
    Ghia, Amol J.
    Sulman, Erik P.
    Penas-Prado, Marta
    de Groot, John F.
    Heimberger, Amy B.
    Wang, Jihong
    Armstrong, Terri S.
    Gilbert, Mark R.
    Guha-Thakurta, Nandita
    Wefel, Jeffrey S.
    NEURO-ONCOLOGY, 2021, 23 (08) : 1337 - 1347
  • [42] A Phase I/II Clinical Trial of Hyperfractionated Concomitant Boost Proton Radiotherapy for Supratentorial Glioblastoma Multiforme
    Tsuboi, K.
    Mizumoto, M.
    Igaki, H.
    Yamamoto, T.
    Takano, S.
    Okumura, T.
    Sakurai, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S231 - S231
  • [43] Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial
    Lai, Shuzhen
    Li, Peijing
    Liu, Xiaohui
    Liu, Guihong
    Xie, Tieming
    Zhang, Xing
    Wang, Xiaoxuan
    Huang, Jing
    Tang, Yiqiang
    Liu, Zhigang
    Shen, Guoping
    Li, Chaoming
    Lu, Fangxiao
    Wang, Lei
    Jiang, Fagui
    Sun, Caixing
    Chen, Yuanyuan
    Chen, Ming
    CANCER BIOLOGY & MEDICINE, 2024, 21 (05)
  • [44] EFFICACY AND SAFETY OF STUPP REGIMEN WITH OR WITHOUT ANLOTINIB FOR NEWLY DIAGNOSED GLIOBLASTOMA: A MULTICENTER, DOUBLE-BLIND, RANDOMIZED PHASE II TRIAL
    Chen, Y.
    Liu, G.
    Sun, P.
    Li, M.
    Yang, X.
    Pan, L.
    Wang, L.
    Hua, Y.
    Zhao, M.
    Liu, Y.
    Ran, J.
    Cai, H.
    Lu, X.
    Jiang, H.
    Li, X.
    Zheng, W.
    Liu, Z.
    Lin, S.
    Deng, M.
    Yang, Q.
    Guo, C.
    Li, J.
    Chen, Z.
    NEURO-ONCOLOGY, 2024, 26
  • [45] Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma
    Faye, Mame Daro
    Easaw, Jacob
    De Robles, Paula
    Agnihotram, Raman
    Torres-Vasquez, Alexander
    Lamonde, Frederic
    Petrecca, Kevin
    Owen, Scott
    Panet-Raymond, Valerie
    Shenouda, George
    Souhami, Luis
    Azam, Maryam
    Hossain, Bushra
    Alkass, Jad
    Sabri, Siham
    Abdulkarim, Bassam
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [46] Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
    Vaz, M. A.
    del Barco, S.
    Sepulveda, J. M.
    Alonso, M.
    Pineda, E.
    Balana, C.
    Martinez-Garcia, M.
    Girones, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S393 - S393
  • [47] SAFETY AND EFFICACY OF BEVACIZUMAB PLUS TTFIELDS IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM): DATA FROM A PHASE II CLINICAL TRIAL
    Fallah, Jaleh
    Chaudhary, Rekha
    Rogers, Lisa
    Wei, Wei
    Brewer, Cathy
    Peereboom, David
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2019, 21 : 18 - 18
  • [48] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    James, Allan
    McBain, Catherine
    Jefferies, Sarah
    Harris, Fiona
    Cseh, Agnieszka
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Brada, Michael
    NEURO-ONCOLOGY, 2018, 20 : 20 - 20
  • [49] TUMOR TREATING FIELDS (TTFIELDS) THERAPY WITH CHEMORADIATION, FOLLOWED BY MAINTENANCE TTFIELDS THERAPY/TEMOZOLOMIDE (TMZ), IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM). RESULTS OF PHASE II CLINICAL STUDY
    Grossman, Rachel
    NEURO-ONCOLOGY, 2024, 26
  • [50] RESULTS OF PHASE I OF THE PARADIGM TRIAL: A PHASE I DOSE ESCALATION STUDY OF OLAPARIB IN COMBINATION WITH SHORT COURSE RADIOTHERAPY IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Chalmers, Anthony
    Stobo, Jon
    Short, Susan C.
    Herbert, Christopher
    Saran, Frank
    Morris, Anna
    Dillon, Susan
    Kelly, Caroline
    NEURO-ONCOLOGY, 2017, 19 : 5 - 5
12345